Literature DB >> 1976247

Dopamine-induced relaxation of the guinea-pig isolated jejunum is not mediated through dopamine receptors.

A Lucchelli1, C Boselli, E Grana.   

Abstract

The possible involvement of specific dopamine receptors in the relaxing effect of dopamine in the guinea-pig isolated jejunum has been investigated. The relaxing effect of dopamine does not show the tachyphylaxis phenomenon and it is present in preparations from guinea-pigs pretreated with reserpine. These results indicate that dopamine has a direct action. Comparison of the effect of dopamine with those of other dopamine receptor agonists, i.e. apomorphine, bromocriptine and the DA1 selective fenoldopam, were made to calculate potency ratios. Since apomorphine, bromocriptine and fenoldopam were shown to relax the guinea-pig jejunum, partly behaving as indirectly acting agents, comparisons were made on reserpine-pretreated guinea-pigs. It has been found that apomorphine is 2.5 times, fenoldopam 3 times and bromocriptine 20 times more active than dopamine in relaxing the guinea-pig jejunum. The order of potency is different from that found in other dopamine receptors containing tissues. The effects of the dopamine receptor blockers, haloperidol and cis-alpha-flupenthixol and the DA1 selective blocker SCH 23390 on the relaxing effect of dopamine were also studied. The relaxing effect of dopamine was not reduced by haloperidol, cis-alpha-flupenthixol and SCH 23390. It is concluded that specific postjunctional dopamine receptors are not involved in the relaxing action of dopamine. Since dopamine is known to interact with alpha- and beta-adrenoceptors in a variety of tissues, the effects of the alpha-adrenoceptor blocker phentolamine and the beta-adrenoceptor blocker propranolol on the relaxing effect of dopamine were also studied. Noradrenaline has been used to check the responsiveness of the tissue. Phentolamine did not block the responses to dopamine and propranolol was able only to partially reduce responses to dopamine, at concentrations higher than those at which it antagonized noradrenaline. Mechanisms other than dopamine, alpha- or beta-receptor activation should be involved in the relaxing effect of dopamine in the guinea-pig jejunum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976247     DOI: 10.1016/1043-6618(90)90750-8

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  6 in total

1.  Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors.

Authors:  Michelangelo Auteri; Maria Grazia Zizzo; Antonella Amato; Rosa Serio
Journal:  J Physiol Biochem       Date:  2017-06-09       Impact factor: 4.158

2.  Luminal dopamine modulates canine ileal water and electrolyte transport.

Authors:  M K Barry; M M Maher; J D Gontarek; R E Jimenez; C J Yeo
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

3.  A pharmacological analysis of receptors mediating the excitatory response to 5-hydroxytryptamine in the guinea-pig isolated trachea.

Authors:  A Lucchelli; M G Santagostino-Barbone; A Barbieri; M Tonini
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

4.  Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice.

Authors:  Zhi Shan Li; Claudia Schmauss; Abigail Cuenca; Elyanne Ratcliffe; Michael D Gershon
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

Review 5.  Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.

Authors:  Sebastiaan P van Kessel; Sahar El Aidy
Journal:  Front Neurol       Date:  2019-10-15       Impact factor: 4.003

6.  Gut bacterial deamination of residual levodopa medication for Parkinson's disease.

Authors:  Sebastiaan P van Kessel; Hiltje R de Jong; Simon L Winkel; Sander S van Leeuwen; Sieger A Nelemans; Hjalmar Permentier; Ali Keshavarzian; Sahar El Aidy
Journal:  BMC Biol       Date:  2020-10-20       Impact factor: 7.431

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.